CYTH
Cyclo Therapeutics Inc - Ordinary Shares - Class A
-43.13%
$1.60 - $0.91
Feb 7th 2023 - Mar 21st 2023
CYTH
Cyclo Therapeutics Inc - Ordinary Shares - Class A
-43.13%
$1.60 - $0.91
Feb 7th 2023 - Mar 21st 2023
positive
negative
Nov, 11, 2022
We definitely fit the bill here.. less than 12 months away from NDA application.. we would be considered late stage drug developer.